RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO) today announced that it has made its initial filing of its First Warning System™ with the Food and Drug Administration. Jim Holmes, Lifeline’s CEO said that “through its consulting firm, Lifeline has submitted the First Warning System™ process and technology to the FDA. The purpose of this filing is to obtain the FDA’s opinion requesting a classification of this device. The opinion as to the classification is expected to determine the subsequent filing and registration required to clear the First Warning System™ for marketing in the United States. The FDA’s response is expected to take several months.”
